Select Medical Holdings CorporationSEMNYSE
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +5.73% | -110.06% | -24.35% | +4.51% | -22.59% |
| Gross Profit Growth | +6.33% | -246.91% | -38.63% | -2.73% | -37.87% |
| EBITDA Growth | +19.07% | -265.12% | -38.07% | -2.02% | -43.63% |
| Operating Income Growth | +8.60% | -448.31% | -41.87% | +17.16% | -48.31% |
| Net Income Growth | +15.46% | -134.69% | -41.50% | -47.69% | -48.24% |
| EPS Growth | +13.16% | -133.33% | -41.33% | -46.67% | -46.51% |
| EPS Diluted Growth | +13.16% | -133.33% | -41.33% | -46.67% | -46.51% |
| Weighted Average Shares Growth | +1.06% | +4.33% | +3.99% | -0.47% | -0.97% |
| Weighted Average Shares Diluted Growth | +1.06% | +4.33% | +1.89% | -0.47% | -0.97% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +55.55% | -30.10% | +0.00% | -60.35% | -3.13% |
| Free Cash Flow Growth | +96.99% | -47.83% | +0.00% | -79.51% | -6.20% |
| Receivables Growth | +12.26% | +13.43% | -19.97% | -15.63% | -22.09% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +4.15% | -27.07% | -27.52% | -27.09% | -28.95% |
| Book Value per Share Growth | +49.47% | +25.09% | +20.92% | +18.24% | -10.93% |
| Debt Growth | -9.02% | -40.23% | -45.46% | -42.50% | -77.42% |
| R&D Expense Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| SG&A Expenses Growth | +14.60% | +81.89% | -31.87% | -28.50% | -15.41% |